These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7794284)

  • 1. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
    Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin.
    Kitamura K; Sakata J; Kangawa K; Kojima M; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1993 Jul; 194(2):720-5. PubMed ID: 7688224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine.
    Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.
    Inatsu H; Sakata J; Shimokubo T; Kitani M; Nishizono M; Washimine H; Kitamura K; Kangawa K; Matsuo H; Eto T
    Biochem Mol Biol Int; 1996 Feb; 38(2):365-72. PubMed ID: 8850532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
    Kitamura K; Kangawa K; Kawamoto M; Ichiki Y; Nakamura S; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1993 Apr; 192(2):553-60. PubMed ID: 8387282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of PAMP-12 (PAMP[9-20]) in porcine adrenal medulla as a major endogenous biologically active peptide.
    Kuwasako K; Kitamura K; Ishiyama Y; Washimine H; Kato J; Kangawa K; Eto T
    FEBS Lett; 1997 Sep; 414(1):105-10. PubMed ID: 9305741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive adrenomedullin in human adrenal glands and adrenal tumors.
    Satoh F; Takahashi K; Murakami O; Totsune K; Sone M; Ohneda M; Abe K; Miura Y; Mouri T
    Cancer Detect Prev; 1997; 21(1):51-4. PubMed ID: 9043763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in PC12 cells after exposure to nerve growth factor.
    Kobayashi H; Itoh S; Yanagita T; Yokoo H; Sugano T; Wada A
    Neuroscience; 2004; 125(4):973-80. PubMed ID: 15120857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adrenomedullin and PAMP].
    Kitamura K; Eto T
    Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP).
    Kitamura K; Kangawa K; Ishiyama Y; Washimine H; Ichiki Y; Kawamoto M; Minamino N; Matsuo H; Eto T
    FEBS Lett; 1994 Aug; 351(1):35-7. PubMed ID: 8076689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide.
    Sakata J; Shimokubo T; Kitamura K; Nakamura S; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1993 Sep; 195(2):921-7. PubMed ID: 7690563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin: a new hypotensive peptide.
    Kangawa K; Kitamura K; Minamino N; Eto T; Matsuo H
    J Hypertens Suppl; 1996 Dec; 14(5):S105-10. PubMed ID: 9120666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenomedullin].
    Bełtowski J
    Postepy Hig Med Dosw; 1999; 53(1):99-123. PubMed ID: 10352550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
    Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
    J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase.
    Nagatomo Y; Kitamura K; Kangawa K; Fujimoto Y; Eto T
    Biochem Biophys Res Commun; 1996 Jun; 223(3):539-43. PubMed ID: 8687431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20).
    Ginda WJ; Nowak KW; Malendowicz LK
    Horm Metab Res; 2000 Jan; 32(1):10-4. PubMed ID: 10727007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
    Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
    Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension.
    Kuwasako K; Kitamura K; Kangawa K; Ishiyama Y; Kato J; Eto T
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():622-8. PubMed ID: 10505213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
    Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
    Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions.
    Kitamura K; Kangawa K; Eto T
    Microsc Res Tech; 2002 Apr; 57(1):3-13. PubMed ID: 11921351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.